SLA 0.00% $3.34 silk laser australia limited

Why certain posters may wish to delay the introduction of bio...

  1. 1,464 Posts.
    Why certain posters may wish to delay the introduction of bio effectives inc. Reopren- from the Solagran info late in 2007.


    "The fact that Solagran’s Bioeffectives® display such a high degree of
    efficacy, while generating few if any side effects, would be anathema to the
    industry." (current pharmaceutical industry)


    The pharma industry does not like non chemical success stories which do not generate side effects which then require more drugs. They don;t want solutions they want sales. SLA provides a potential solution.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.